Tenecteplase for Acute Ischemic Stroke - INTERNAL, NO CME

Intravenous thrombolytics is the mainstay of acute therapy in ischemic stroke.  While alteplase has been FDA-approved for this indication since the 1990s, Tenecteplase has recently gained traction for usage in acute ischemic stroke treatment as well.  This lecture summarizes the existing evidence and practical considerations for use of Tenecteplase in stroke therapy.  

Target Audience

ED Physicians

Internal Medicine Physicians


Stroke Coordinators



Learning Objectives

Learners will be able to:

  • define the usage of tenecteplase for acute ischemic stroke
  • assess the utility of tenecteplase as an alternative to alteplase in the correct setting
  • analyze some of the data from major tenecteplase trials
  • demonstrate knowledge of proper tenecteplase administration techniques and protocols
Course summary
Available credit: 
  • 1.00 Participation
Course opens: 
Course expires: 

Available Credit

  • 1.00 Participation
Please login or register to take this course.